Event calendar.

Meet us

| 2-5 September 2018 | 54th Congress of the European Societies of Toxicology EUROTOX, Brussels, Belgium
The theme for 2018 is “Toxicology Out of the Box”. SenzaGen will be exhibiting  and presenting at the conference.


“Exploration of the GARD applicability domain – Sensitization assessment of UVCBs” (Abstract ID: 213)
Monday, Sept 3, Poster viewing 1

“Predicting Skin Sensitizers with Confidence – Using Conformal Prediction to Determine Applicability Domain of GARD” (Abstract ID: 628),
Monday, Sept 3, Poster viewing 1

“The Validation of GARDskin” (Abstract ID: 659)
Tuesday, Sept 4, Poster viewing 2

Late breaking – “Extended applicability domain with new solvent selection for the GARD platform”

Booth: 12 

Link to conference |

| 20-21 September 2018 | 2nd International Conference on Alternative Methods for Cosmetics, Bijing, China

SenzaGen will participate in the 2nd International Conference on Alternative Methods for Cosmetics in Beijing. A two day event organized by National Institutes for Food and Drug Control (NIFDC) , the most prominent institutes for validation of new in vitro test methods for cosmetics in China.

| Link to conference (Chinese) |

| 23–26 September 2018 | EUSAAT, Linz, Austria
EUSAAT, the European Society for Alternatives to Animal Testing, is the European 3Rs Society. EUSAAT is actively promoting the protection of experimental animals according to the 3Rs-Principle (refine – reduce – replace).
SenzaGen will be participating the event.
Link to conference |

| 25– September 2018 | North American Biocompability Summit, Minneapolis, US

SenzaGen is participating at The North American Biocompatibility Summit.
The event will provide industry insights and expertise sharing on the biocompatibility of medical devices, including the latest regulatory updates, biological evaluation strategies and best practices that lead to successful biocompatibility programs.

Link to conference |

| 2 October 2018 | Understanding Biocompatibility of Medical Devices, Medicon Village, Lund
SenzaGen are the hosts of this  Medicon Valley MedTech Network meeting.

The regulatory framework of the medical device industry is going through major changes and the complexity of the process is increasing due to new requirements and standards. All medical devices that come into physical contact with patients must be assessed for allergy. Therefore, manufacturers must conduct biological safety evaluations before market approval.

Welcome to join us at the next Medicon Valley MedTech Network meeting to learn more about ISO 10993* and the recent changes in the standard, and understand how to make a biological evaluation of your medical device products.
Link to conference |

| 3-4 October 2018The 7th Medicon Valley Inhalation Symposium – Future Opportunities of Inhalation 2018, Medicon Village, Lund

SenzaGen is proud to sponsor, exhibit and present at MVIC’s Symposium, MVIS, 2018

Date: Wednesday the 3rd of October – Thursday the 4th of October 2018
Time: Day 1: 09.00–18.00. Day 2: 09.00–13.00
Place: Medicon Village, Lund, Sweden

Presentation, Day 2: 09.25–09.50 , Predictive Respiratory Toxicology with the GARD In-Vitro Testing Platform, Dr Henrik Johansson, SenzaGen AB
Link to conference program |

| 15–18 October 2018 | 20th International Congress on In Vitro Toxicology, Berlin
SenzaGen is proud to sponsor, exhibit and present poster at the ESTIV conference, 2018
Emphasis will be specifically on how new technologies can strengthen the interpretation and application of in vitro methods in toxicological research and risk assessment.
Link to conference |

| 5–7 November 2018 | Bio Europe, Copenhagen, Denmark
24th annual conference
Link to conference |

| 27-29 November 2018 | Biocompatibility for Medical Devices, Barcelona, Spain
Link to conference |